NIH-funded research R01 grant

FKBP5's role in heart rhythm and potential AF therapies

Official title: FKBP5 AND CARDIAC ARRHYTHMOGENESIS

Funded at Baylor College of Medicine · NIH-11503065 · Data updated 2026-11-12

A Baylor College of Medicine team is studying how FKBP5 in the heart affects atrial fibrillation and whether targeting this pathway could lower AF risk.

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionBaylor College of Medicine
NIH-funded
Lab location1 site (Houston, United States)
Project startDecember 20, 2023
Project endNovember 30, 2027
Funding year2026
Award (this year)$90,523
NIH project number3R01HL164838-03S2
Project IDNIH-11503065 on NIH RePORTER

Who could benefit from this research

Could help

People with or at risk for atrial fibrillation who might benefit from future FKBP5-targeted therapies.

Less likely to help

Patients without AF or AF risk factors may not experience direct benefits from this research.

What this research studies

This research looks at how reducing FKBP5 in heart cells and heart-supporting tissue may lead to atrial fibrillation by increasing abnormal electrical activity and promoting fibrotic changes. The team will use models to separate the effects in heart muscle cells versus fibroblasts, aiming to understand the exact mechanisms. If successful, the work could point to new therapeutic strategies to prevent or treat AF by modulating FKBP5 pathways.

Why it matters

Potential benefit: Could lead to new ways to prevent or treat atrial fibrillation by targeting FKBP5-related mechanisms.

How similar studies have gone: Previous findings that FKBP5 deficiency links to increased AF risk justify exploring this pathway further, with potential for new therapies.

Where this research is happening

  • Baylor College of Medicine
    Houston, United States
    Active

Researchers

  • Principal investigator: Li, Na — Baylor College of Medicine
  • Study coordinator: Li, Na

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.